You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海医药(02607.HK)拟成立投资基金 参与医疗产业链战略布局
格隆汇 10-29 17:06

格隆汇 10 月 29日丨上海医药(02607.HK)公告,于2020年10月29日,公司订立合伙协议,内容有关设立预期规模为人民币90亿元,且首期认购结束时规模为人民币70亿元的投资基金,据此,公司(作为有限合伙人)、上海上实(作为有限合伙人)、国泰君安母基金(作为有限合伙人)、临港投资(作为有限合伙人)、国际集团(作为有限合伙人)、长宁投资(作为有限合伙人)、上海上投(作为有限合伙人)及上海生物医药产业基金(作为普通合伙人)已分别同意认购人民币15亿元、人民币20亿元、人民币14亿元、人民币10亿元、人民币5亿元、人民币5亿元、人民币0.5亿元及人民币0.5亿元的投资基金份额。

名称上海生物医药产业股权投资基金合伙企业(有限合伙)(暂定名)。

通过订立合伙协议成立投资基金,公司不仅可以获取合理投资收益,还将与投资基金进行多方面的战略合作并发挥协同作用,通过参与医疗产业链中创新企业的孵化与培育优化公司的战略布局。成立投资基金亦有利于扩大公司对私募基金行业的影响力及品牌效应,并吸引更多优质项目资源。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account